# 3 FTSE 250 Directorate changes, Baillie Gifford Japan, Dechra Pharmaceuticals and Great Portland Estates

- Link: https://www.directorstalkinterviews.com/3-ftse-250-directorate-changes-baillie-gifford-japan-dechra-pharmaceuticals-and-great-portland-estates/4121121792
- Published: 2023-06-16T14:10:44+01:00
- Author: Jacob Brown

The Board of **The Baillie Gifford Japan Trust PLC** (LON:BGFD) has announced the
appointment of Patricia Lewis as a non-executive Director of the Company with effect
from 1 August 2023.

Patricia is a financial services executive with 25 years experience advising clients
in global capital markets, investment management, risk management, marketing strategy
and investor relations with responsibility for business growth and profitability.
Her experience was garnered over her investment banking career at Bank of America
Merrill Lynch in corporate finance and capital markets, most recently as Managing
Director and Head of EMEA Loans and Special Situations Sales. Currently, she is 
a non-executive director of Snowball Impact Management Limited and a member of their
Impact Investment Committee. 

Further to the announcement by **Dechra Pharmaceuticals** (LON:DPH) made on 20 December
2022 which stated that Ishbel Macpherson intended to step down as a Non-Executive
Director of the Company on 30 June 2023, she has informed the Board that she has
decided to tender her resignation and step down from the Board on 22 June 2023.

> **Alison Platt, Chair, Dechra said:**
> _Ishbel’s contribution to the Board over the last ten years has been outstanding
> and we wish her well in her future endeavours. We would like to thank her for 
> the additional time spent on the Board to enable Dechra to appoint a replacement
> Non-Executive Director and Remuneration Committee Chair._

**Great Portland Estates plc** (LON:GPE) has announced that Karen Green will join
the Board as a Non-Executive Director with effect from 1 December 2023 and will 
become a member of the Audit, Remuneration and Nomination Committees from that date.

Karen is currently a Non-Executive Director, Senior Independent Director and Chair
of the [Sustainability](https://www.directorstalkinterviews.com/sustainability-green-stocks-news)
Committee at [Phoenix Group Holdings plc](https://www.directorstalkinterviews.com/ftse-company/phoenix-group-holdings/phnx.l),
a Non-Executive Director and Chair of the Audit Committee at [Admiral Group plc](https://www.directorstalkinterviews.com/ftse-company/admiral-group/adm.l)
and a Council Member and Chair of the Investment Committee at Lloyd’s of London.
Karen will not be seeking re-election to Lloyd’s of London when her current term
expires on 30 November 2023, as she approaches the end of her nine-year tenure.

Karen previously spent over six years, until 2017, as Chief Executive of Aspen UK,
which comprised the UK insurance and reinsurance companies of US-listed Aspen Insurance
Holdings. She also held a number of other senior positions at Aspen including Group
Head of Strategy and Corporate Development. Prior to that, she held various senior
corporate finance, M&A and private equity roles at GE Capital and then MMC Capital(
now Stone Point Capital), having started her career as an investment banker at Baring
Brothers and then [Schroders plc](https://www.directorstalkinterviews.com/ftse-company/schroders-plc/sdr.l).

> **Commenting on the appointment, GPE Chair Richard Mully said:**
> “I am delighted that Karen will be joining the GPE Board, bringing her considerable
> City, financial markets and non-executive experience. The Board and I very much
> look forward to working with her.”

Share on: